weight loss shot retatrutide Some Providers Prescribe Unapproved for at Alarming Rate Retatrutide for weight loss: Study

Some lost less

2024 DOI: 10.1038/s41421-024-00702-y PMID: 39019866 Read on PubMed European Journal of Clinical Pharmacology A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity Kaur M, Misra S 2024 DOI: 10.1007/s00228-024-03646-0 PMID: 38367045 Read on PubMed Cardiology in Review The First Triple Agonist for Antiobesity: Retatrutide Tetelbaum L, Mullally JA, Frishman WH 2024 DOI: 10.1097/CRD.0000000000000793 PMID: 39724554 Read on PubMed NPJ Metabolic Health and Disease Incretin triple agonist retatrutide alleviates obesity-associated cancer progression Marathe SJ, Grey EW, Bohm MS, et al

GLP-1 drugs can be a helpful tool, but theyre not magic

Abbreviations Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and dual GIP/GLP-1 receptor agonists (GIP/GLP-1RAs) have undergone evaluation across an extensive cardiovascular outcomes trial (CVOT) program

You might recognize other prescription drugs in this group such as Wegovy, Zepbound and Mounjaro